HomeInsightsStock Comparison

Onesource Specialty Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Onesource Specialty Pharma Ltd vs Sms Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 29, 2025

Key Highlights

  • The Latest Trading Price of OneSource Specialty Pharma Ltd is ₹ 2194 as of 27 Jun 15:30.
  • The P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of SMS Pharmaceuticals Ltd changed from 7.1 on March 2020 to 30.2 on March 2024 . This represents a CAGR of 33.58% over 5 years.
  • The Market Cap of OneSource Specialty Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of SMS Pharmaceuticals Ltd changed from ₹ 225.6 crore on March 2020 to ₹ 1507 crore on March 2024 . This represents a CAGR of 46.21% over 5 years.
  • The revenue of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 428.84 crore as compare to the Dec '24 revenue of ₹ 399.28 crore. This represent the growth of 7.4% The revenue of SMS Pharmaceuticals Ltd for the Mar '25 is ₹ 249.62 crore as compare to the Dec '24 revenue of ₹ 175.48 crore. This represent the growth of 42.25%.
  • The ebitda of OneSource Specialty Pharma Ltd for the Mar '25 is ₹ 184.72 crore as compare to the Dec '24 ebitda of ₹ 48.08 crore. This represent the growth of 284.19% The ebitda of SMS Pharmaceuticals Ltd for the Mar '25 is ₹ 42.23 crore as compare to the Dec '24 ebitda of ₹ 35.34 crore. This represent the growth of 19.5%.
  • The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 98.5 crore over 8 quarters. This represents a CAGR of NaN% The net profit of SMS Pharmaceuticals Ltd changed from ₹ 8.81 crore to ₹ 20.08 crore over 8 quarters. This represents a CAGR of 50.97% .
  • The Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of SMS Pharmaceuticals Ltd changed from 6.48 % on March 2020 to 6.86 % on March 2024 . This represents a CAGR of 1.15% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

About SMS Pharmaceuticals Ltd

  • SMS Pharmaceuticals Limited was incorporated in December, 1987.
  • The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates.
  • Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh.
  • Its business activity is a single primary business segment of 'Bulk Drugs'. During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs.

OneSource Specialty Pharma Ltd News Hub

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

News

Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane

Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a pa...

Read more

11 Jun 2025 10:09

News

OneSource Specialty jumps as Bangalore facility passes USFDA check

The facility received a Voluntary Action Indicated (VAI) classification from the USFDA, fo...

Read more

10 Jun 2025 10:16

News

OneSource receives ratings action from India Ratings & Research

OneSource Specialty Pharma announced that India Ratings & Research has assigned the credit...

Read more

04 Jun 2025 12:48

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Apr 2025 11:35

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

25 Jan 2025 10:23

SMS Pharmaceuticals Ltd News Hub

News

SMS Pharma's Hyderabad facility clears USFDA inspection with zero observations

The inspection was conducted from 23rd June 2025 to 25th June 2025, concluded with zero Fo...

Read more

26 Jun 2025 08:27

News

Board of SMS Pharmaceuticals recommends final dividend

SMS Pharmaceuticals announced that the Board of Directors of the Company at its meeting he...

Read more

31 May 2025 14:45

News

SMS Pharmaceuticals to announce Quarterly Result

SMS Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

24 May 2025 18:31

News

SMS Pharmaceuticals' Unit VII receives WHO Geneva prequalification

SMS Pharmaceuticals announced that Unit VII manufacturing facility in Visakhapatnam, Andhr...

Read more

02 May 2025 12:36

News

SMS Pharma gains after Hyderabad facility completes USFDA inspection

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

24 Mar 2025 09:59

News

SMS Pharma's Hyderabad facility completes USFDA inspection with 1 observation

According to an exchange filing, the inspection was conducted from 17 March to 21 March 20...

Read more

22 Mar 2025 16:28

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

2

T

BlinkX Score for SMS Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd

Which company has a larger market capitalization, OneSource Specialty Pharma Ltd or SMS Pharmaceuticals Ltd?

Market cap of OneSource Specialty Pharma Ltd is 25,112 Cr while Market cap of SMS Pharmaceuticals Ltd is 2,203 Cr

What are the key factors driving the stock performance of OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd?

The stock performance of OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd?

As of June 29, 2025, the OneSource Specialty Pharma Ltd stock price is INR ₹2194.45. On the other hand, SMS Pharmaceuticals Ltd stock price is INR ₹248.6.

How do dividend payouts of OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd compare?

To compare the dividend payouts of OneSource Specialty Pharma Ltd and SMS Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions